全球牙科生物材料市场-2022-2029

市场动态

牙科疾病患病率上升、老年人口不断增长、对美容牙科的需求不断增加、牙科和口腔护理支出增加、采用新型粘合剂、CAD/CAM 中的树脂粘固剂和其他数字技术在

预计口腔疾病的增长将推动市场增长。

牙周病、蛀牙、口腔癌、龋齿和口臭等口腔疾病正在推动市场增长。根据美国疾病控制和预防中心 (CDC) 的数据，在 46% 的 30 岁以上人群中发现了牙周病的迹象，严重牙周病影响约 9% 的成年人。此外，未经治疗的蛀牙影响了美国约 26% 的人。此外，根据美国国立牙科和颅面研究所的数据，92% 的 20 至 64 岁的成年人的恆牙有蛀牙，平均严重程度为 3.28 个蛀牙和 13.65 颗恆牙缺失，据说有。提高对中低收入国家牙科植入物重要性的认识预计将推动整个预测期内的市场增长。此外，随着发达国家可支配收入的增加，对牙齿美白和牙龈轮廓等美容程序的需求也在增加。因此，从上述陈述来看，预计市场将在预测期内受到驱动。

约束

高昂的治疗成本、严格的法规和临床流程以及低保险报销将在预测期内抑制市场。

行业分析

牙科生物材料市场根据各种行业因素（包括未满足的需求、定价分析、供应链分析和监管分析）对市场进行深入分析。

内容

第一章研究方法与范围

• 调查方法
• 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

• 按产品划分的市场细分
• 按类型划分的市场细分
• 按应用划分的市场细分
• 最终用户的市场细分
• 按地区划分的市场细分
• DataM CLO 场景

第 4 章市场动态

• 市场影响因素
  • 驱动程序
    • 牙科疾病的患病率增加
    • 不断增长的老年人口
    • 牙科费用增加
    • 技术进步
  • 限制因素
    • 治疗费用高
    • 严格的监管和临床流程
  • 商机
  • 影响分析

第五章行业分析

• 波特五力分析
• 供应链分析
• 监管分析
• 流行病学

第 6 章按产品分类

• 骨移植材料
  • 沿着嫁接
  • 异种移植
  • 合成树脂
• 牙膜
• 软组织再生材料
• 其他（牙科粘固剂、牙科印模材料）

第 7 章按类型

• 金属
• 陶瓷
• 天然牙科生物材料

第 8 章按应用程序

• 种植体领域
• 牙周病学
• 牙科修復
• 正畸
• 其他

第 9 章，最终用户

• 种植牙和假牙製造商
• 牙科实验室
• 牙科医院/牙科诊所
• 其他（牙科学院、研究所等）

第 10 章按地区划分

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 意大利
  • 西班牙
  • 其他欧洲
• 南美洲
  • 巴西
  • 阿根廷
  • 其他南美洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 其他亚太地区
• 中东和非洲

第 11 章竞争格局

• 竞争场景
• 竞争性牙科生物材料战略分析
• 比较产品组合分析
• 市场情况/份额分析
• 併购分析

第 12 章公司简介

• Straumann AG
  • 公司概况
  • 产品组合和描述
  • 主要亮点
  • 财务摘要
• Geistlich Pharma AG
• Zimmer Biomet Holdings, Inc.
• Danaher Corporation
• Dentsply Sirona, Inc.
• 3M Company
• Royal DSM
• Kuraray Co., Ltd
• Medtronic Plc.
• Henry Schein, Inc.
• Victrex Plc
• Ivoclar Vivadent AG
• BEGO Medical GmbH

第13章 DataM

Market Overview

The Dental Biomaterials Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.7% during the forecast period (2022-2029)

Dental biomaterials are specialized natural or synthetic products designed to be used in preventive and restorative dentistry. These products are used to restore damaged, decayed, or fractured teeth. Dental biomaterials are efficient products with a high success rate in oral treatment and prevention. These products replace the damaged or missing tooth tissues and also promote tissue regeneration. Natural biomaterials include enamel, dentin, cementum, bone, and other intraoral tissues and synthetic materials include metals, ceramics, polymers, and composite structures.

Market Dynamics

The market is driven by the growing prevalence of dental disorders, rising geriatric population, increasing demand for cosmetic dentistry, increase in expenditure on dental and oral care, and increasing adoption of novel adhesives, resin cement in CAD/CAM, and other digital technologies.

The increasing prevalence of oral disorders is expected to drive market growth.

Oral disorders such as periodontal disease, tooth decay, oral cancer, dental caries, and halitosis, among others, are driving the market growth. According to the Centers for Disease Control and Prevention (CDC), indications of gum disease are present in 46 percent of all persons aged 30 and older, with serious gum disease affecting approximately 9% of adults. Untreated dental decay affects approximately 26% of persons in the United States. Furthermore, according to the National Institute of Dental and Craniofacial Research, 92 percent of adults aged 20 to 64 have dental caries in their permanent teeth, with an average severity of 3.28 decayed or missing permanent teeth and 13.65 decaying and missing permanent teeth. Increased awareness of the significance of dental implants in middle and low-income nations will drive market growth throughout the forecast period. Aside from that, as disposable income in industrialized countries has increased, so has demand for aesthetic procedures like teeth whitening and gum contouring. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

High cost of treatment, presence of stringent regulatory and clinical processes, and low reimbursement coverage by insurance are going to restrain the market in the forecast period.

Industry Analysis

The dental biomaterials market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

Polymeric Biomaterials segment is expected to hold the largest market share in the dental biomaterials market.

The polymeric biomaterials segment accounted for the largest market share in 2021. The segment benefits because of high product durability, reduced risks of infections compared to other materials, material flexibility that provides ease in shape formation, biocompatibility, good resilience, lightweight, easy fabrication, and high corrosion resistance. Moreover, polymeric biomaterials have unique antimicrobial and drug delivery properties in preventive, regenerative, and restorative therapies to reduce friction and corrosion in dentistry. Therefore, it has increased the demand for polymeric biomaterials. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global dental biomaterials market.

The North American region accounted for the largest market share in 2021. Owing to the increasing prevalence of caries and the presence of major players within the region, high dental expenditure within the Americas are the factors to drive the market growth. For instance, according to a recent paper by the American College of Prosthodontists, more than 36 million Americans are toothless, and 120 million have at least one missing tooth. Such circumstances in the Americas increase the demand for prosthodontics and implants. Moreover, Pulpdent Corporation, a dental research and manufacturing business in the Greater Boston area, launched ACTIVA Presto dental material in January 2020. The new white dental filling material has qualities similar to natural teeth. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the dental biomaterials market are Straumann AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Kuraray Co., Ltd, Medtronic Plc., Henry Schein, Inc., Mitsui Chemicals, Inc., Victrex Plc, Ivoclar Vivadent AG, GC Corporation, Keystone Dental, Inc., Datum Dental Ltd, BEGO Medical GmbH, Cam Bioceramics B.V., Geistlich Pharma AG, BioHorizons IPH, Inc., and Biomatlante.

Straumann:

Straumann is a global leader in implant, restorative and regenerative dentistry. The company researches, develop, and manufacture dental implants, instruments, prosthetics, and tissue and bone regeneration biomaterials in collaboration with leading clinics, research institutes, and universities for tooth replacement and restoration or to prevent tooth loss. The company has six production sites for implants, biomaterials and CAD/CAM in Europe, the United States and Japan. Its extensive network of distribution subsidiaries and partners makes its products and services available in over 70 countries. The company's periodontal product portfolio includes Straumann Emdogain FL, leading to true periodontal regeneration based on biomimicry.

Product Portfolio:

Straumann XenoFlex: Straumann XenoFlex is a biomimetric composite material that resembles the native bone in its basic biphasic composition of collagen and xenogenic hydroxyapatite. It has beneficial handling characteristics and the ability to be shaped to match the individual defect situation. Straumann XenoFlex - an efficient, easy to handle, volume stable solution for the treatment of bone defects.

The global dental biomaterials market report would provide an access to an approx. 45+market data table, 40+figures

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet by Product
• 3.2. Market Snippet by Type
• 3.3. Market Snippet by Application
• 3.4. Market Snippet by End User
• 3.5. Market Snippet by Region
• 3.6. DataM CLO Scenario

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing prevalence of dental disorders
    • 4.1.1.2. Rising geriatric population
    • 4.1.1.3. Increase in expenditure on dental
    • 4.1.1.4. Technological advancements
  • 4.1.2. Restraints
    • 4.1.2.1. High cost of treatment
    • 4.1.2.2. Stringent regulatory and clinical processes
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Regulatory Analysis
• 5.4. Epidemiology

6. By Product

• 6.1. Introduction
• 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
• 6.3. Market Attractiveness Index, By Product
• 6.4. Bone Graft Materials*
  • 6.4.1. Introduction
  • 6.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 6.4.3. Allografts
  • 6.4.4. Xenografts
  • 6.4.5. Synthetic
• 6.5. Dental Membranes
• 6.6. Soft Tissue Regeneration Products
• 6.7. Others (dental cement, dental impression materials)

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Metallic
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
• 7.3. Ceramic
• 7.4. Natural Dental Biomaterials

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Implantology
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
• 8.3. Periodontology
• 8.4. Prosthodontics
• 8.5. Orthodontics
• 8.6. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Dental implant and prosthetic manufacturers
  • 9.4.1. Introduction
  • 9.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
• 9.3. Dental laboratories
• 9.4. Dental hospitals and clinics
• 9.5. Others (Dental academies and research institutes)

10. By Region

• 10.1. North America
  • 10.1.1. U.S.
  • 10.1.2. Canada
  • 10.1.3. Mexico
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. South America
  • 10.3.1. Brazil
  • 10.3.2. Argentina
  • 10.3.3. Rest of South America
• 10.4. Asia Pacific
  • 10.4.1. China
  • 10.4.2. India
  • 10.4.3. Japan
  • 10.4.4. Australia
  • 10.4.5. Rest of Asia Pacific
• 10.5. Middle East and Africa

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Competitor Dental Biomaterials Strategy Analysis
• 11.3. Comparative Product Portfolio Analysis
• 11.4. Market Positioning/Share Analysis
• 11.5. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Straumann AG*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Geistlich Pharma AG
• 12.3. Zimmer Biomet Holdings, Inc.
• 12.4. Danaher Corporation
• 12.5. Dentsply Sirona, Inc.
• 12.6. 3M Company
• 12.7. Royal DSM
• 12.8. Kuraray Co., Ltd
• 12.9. Medtronic Plc.
• 12.10. Henry Schein, Inc.
• 12.11. Victrex Plc
• 12.12. Ivoclar Vivadent AG
• 12.13. BEGO Medical GmbH

13. DataM Intelligence

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3 Contact Us